Ph.D. in Biotechnology, Life Sciences with at least two years of research experience in zebrafish biology. Experience in performing zebrafish experiments and skills in molecular biology are required. Candidates with publications in the relevant field will be given preference.
The candidate must have a PhD in any branch of Life Sciences from a reputed University, Institute. Proven ability to teach MSc level students and conduct laboratory sessions (theory and practical topics related to Mammalian Cell Culture, Histochemistry, Flow cytometry, Confocal imaging, Microbiology and Molecular Biology is necessary in this role
The candidates should have knowledge of basic chemistry, chemical reactions, chemistry experiments, materials, electrochemistry, polymer chemistry, Physical chemistry, and catalysis.
Review of approved vendor list in-line with submitted, current DMF. Review of Raw materials, Packing materials specification and analytical procedures. Preparation of ODMF, Technical package as per customer requirement.
Review of BPR, batch cleaning record, test data sheet, Sampling of API finished goods. Preparation of APQR. Handing of QMS document Change control, Deviation, CAPA, OOS, OOT review.
GSK plc announced positive headline results of MATINEE, the phase III clinical trial evaluating Nucala mepolizumab, a monoclonal antibody that targets interleukin-5 in adults with chronic obstructive pulmonary disease.
Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company, has been at the forefront of healthcare since 1907. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA. Alembic is one of the leaders in branded generics in India.
Strides Pharma Science Limited announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval for the generic version of Theophylline Extended-Release Tablets, 300 mg and 450 mg, from the United States Food & Drug Administration